Hsu C H, Chen P S, Smith D E, Yang C S
Miner Electrolyte Metab. 1986;12(2):130-41.
The etiology of hypercalciuria remains unknown in spontaneously hypertensive rats (SHR). In order to differentiate absorptive versus renal hypercalciuria, serial measurements of urinary calcium (UCaV) excretion were made weekly under fasting (3-hour urine collection) and after oral administration of CaCl2 (50 mg/100 g; 4-hour urine collection) from age 8 to 14 weeks in SHR (n = 14) and normotensive Wistar Kyoto rats (WKY; n = 14). Fasting UCaV was significantly greater in WKY than in SHR throughout the periods of observation. In contrast, after oral Ca loading UCaV was greater in SHR after 13 weeks of age (13 weeks: SHR UCaV = 954 micrograms/mg creatinine, WKY UCaV = 541 p less than 0.01; 14 weeks: SHR UCaV = 988 micrograms/mg creatinine, WKY UCaV = 534, p less than 0.01). Fasting urinary cyclic adenosine monophosphate (AMP) excretion was not different between WKY and SHR. However, cyclic AMP excretion of SHR, but not WKY, was decreased after calcium loading when compared to the fasting values. The cyclic AMP was also significantly lower in SHR than in WKY rats after calcium loading. Calcium handling by the kidney was not different between SHR and WKY with or without parathyroidectomy. Calcium disposition kinetic studies were performed on these animals at age 15 and 16 weeks. No significant difference of intravenous 45Ca was observed between WKY (n = 6) and SHR (n = 6) in total plasma clearance, nonrenal clearance, biologic half-life, and elimination rate constant from the central compartment. However, the WKY had a significantly greater renal clearance of 45Ca than the SHR (0.48 +/- 0.04 vs. 0.24 +/- 0.02 ml/n, p less than 0.001). Since tissue disposition of intravenous 45Ca was not different between WKY and SHR, the increased renal excretion of calcium after oral administration in SHR, therefore, reflects increased intestinal absorption of calcium. Correction of established hypertension did not abolish the hypercalciuria. We believe that increased gastrointestinal absorption of calcium is responsible for the hypercalciuria in SHR.
自发性高血压大鼠(SHR)高钙尿症的病因尚不清楚。为了区分吸收性高钙尿症与肾性高钙尿症,在8至14周龄期间,每周对SHR(n = 14)和血压正常的Wistar Kyoto大鼠(WKY;n = 14)进行空腹(收集3小时尿液)和口服氯化钙(50 mg/100 g;收集4小时尿液)后尿钙(UCaV)排泄的系列测量。在整个观察期间,WKY的空腹UCaV显著高于SHR。相反,13周龄后SHR口服钙负荷后的UCaV更高(13周:SHR的UCaV = 954微克/毫克肌酐,WKY的UCaV = 541,p < 0.01;14周:SHR的UCaV = 988微克/毫克肌酐,WKY的UCaV = 534,p < 0.01)。WKY和SHR的空腹尿环磷酸腺苷(AMP)排泄无差异。然而,与空腹值相比,SHR而非WKY在钙负荷后环磷酸腺苷排泄减少。钙负荷后SHR的环磷酸腺苷也显著低于WKY大鼠。无论有无甲状旁腺切除术,SHR和WKY肾脏对钙的处理均无差异。在15和16周龄时对这些动物进行了钙处置动力学研究。在总血浆清除率、非肾清除率、生物半衰期和中央室消除速率常数方面,WKY(n = 6)和SHR(n = 6)之间未观察到静脉注射45Ca的显著差异。然而,WKY的45Ca肾清除率显著高于SHR(0.48 ± 0.04对0.24 ± 0.02 ml/n,p < 0.001)。由于WKY和SHR之间静脉注射45Ca的组织处置无差异,因此,SHR口服给药后钙的肾排泄增加反映了肠道钙吸收增加。已确立的高血压得到纠正并未消除高钙尿症。我们认为,胃肠道钙吸收增加是SHR高钙尿症的原因。